miraDry

What miraDry does

miraDry, Inc. is a private medical technology company founded in 2007 and headquartered in Newport Beach, California, that developed the FDA-cleared miraDry System (MN-MD4000-MS) for the permanent reduction of underarm sweat, odor, and hair. The core technology uses controlled microwave thermal energy delivered through a proprietary handpiece (MN-MD4000-HP) and bioTip (MN-MD4000-TP) to destroy sweat glands, odor glands, and hair follicles at the dermal-hypodermal interface in a single, approximately one-hour outpatient procedure. The company protects the architecture with a layered US patent estate (method, system, and design patents including 8,401,668, 8,535,302, 9,028,477, 9,149,331, 10,463,429, 10,624,696, 10,779,887, 11,123,136, 11,419,678, and 12,186,015, plus design patents D636,087 and D713,537) and holds FDA clearance for the device's sweat, odor, and hair-removal indications, with EU MDR certification secured in July 2025.

The business model is a procedure-revenue model operated through a trained-and-certified provider channel: miraDry does not sell directly to patients but supplies devices and treatment protocols to dermatologists, plastic surgeons, med spa operators, and other licensed aesthetic practitioners who bill patients per treatment, with pricing varying by region and practice. Distribution is global, spanning 35+ countries via direct enterprise field sales in North America and an international distributor network in Europe, Asia Pacific, the Middle East, Africa, and Latin America. Demand is generated through a hybrid marketing approach combining educational content (blog, social media, earned media in outlets such as Allure, Glamour, and the New York Times), industry events (A4M, AmSpa, ASLMS, IMCAS), monthly provider training webinars, and awareness campaigns such as Odor Awareness Week and Hyperhidrosis Awareness Month run in partnership with the International Hyperhidrosis Society.

The company serves two interlocking customer segments: end patients experiencing hyperhidrosis, bromhidrosis, or unwanted underarm hair who seek a permanent non-surgical solution, and medical aesthetic provider practices that monetize miraDry as a high-margin differentiated offering. Recent performance signals include 55% year-over-year growth in patient spend and 43% year-over-year growth in total treatments for Q1 2026, compared with roughly 4% growth in the broader medical aesthetic energy-based device market. The leadership team comprises CEO Robert Catlin and Chair Amber Edwards (both appointed January 2023) and COO Trish Howell (appointed May 2025). No venture capital funding rounds, parent company, or public-market listing are disclosed.

Name

miraDry

Legal name

miraDry, Inc.

Website

https://miradry.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

101–250 employees

Short description

miraDry is a private medical technology company that sells an FDA-cleared, microwave-based device used by trained dermatologists, plastic surgeons, and med spas to permanently eliminate underarm sweat, odor, and hair in a single outpatient procedure, distributed across 35+ countries.

Ownership category

akta.pro rank

Product category

Medical Aesthetic Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Skincare Devices (Cleansing Brushes, Microcurrent, LED, Dermaplaning) (CRABAKAI)

Keywords

• Medical aesthetic devices
• Hyperhidrosis treatment
• Microwave energy devices
• Underarm sweat reduction
• Aesthetic medical equipment

Headquarters

HQ city

Santa Clara

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Marketing or Sales, Personnel, Supply Chain, Operations

Revenue model

1. Procedure/Treatment Revenue: miraDry generates revenue through the sale of treatments performed by its network of provider partners. Patients pay for the miraDry procedure, which is performed by licensed healthcare practitioners in medical aesthetic practices, dermatology offices, and other clinical settings. Pricing varies by region and practice.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

miraDry manufactures and distributes the miraDry System (MN-MD4000-MS), an FDA-cleared medical device that uses controlled microwave thermal energy to permanently eliminate sweat glands, odor glands, and hair follicles in the underarm area. The company sells the device and its proprietary handpiece and bioTip components to a global network of licensed medical professionals—including dermatologists, plastic surgeons, and med spa operators—who perform the approximately one-hour, non-invasive miraDry procedure on patients in clinical settings.

Product overview

miraDry offers a non-invasive medical treatment system that uses thermal energy (microwave technology) to permanently eliminate sweat glands, odor glands, and hair follicles in the underarm area. The core product is the miraDry System (MN-MD4000-MS), which comprises the handpiece (MN-MD4000-HP) and bioTip (MN-MD4000-TP) components. The treatment is FDA-cleared for reduction of underarm sweat and odor, and takes approximately one hour in an outpatient setting with local anesthesia. The miraDry System and miraDry fresh are trademarks of miraDry, Inc.

Differentiator

Problem solved

Functional benefit

Brands

• miraDry fresh: Trademark brand associated with miraDry odor reduction treatments.

Quantifiable outcome

• 82% average sweat reduction at 12 months
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core and minor.

• International Hyperhidrosis Society (Odor Awareness Week)coreGTM or Marketing Partner · 22 April 2026Annual Odor Awareness Week initiative featuring educational webinars and community engagement. Led by Chris Callewaert, also known as 'Dr. Armpit.'
• MellingMedicalminorChannel Partner/ Reseller/ Distributor · 11 July 2023MellingMedical offers miraDry to federal medical centers, expanding access to military and government healthcare facilities.
• International Hyperhidrosis SocietycoreStrategic or Co-development Partner · 26 June 2023miraDry partnered with the International Hyperhidrosis Society to advance hyperhidrosis treatment and support patients worldwide. The partnership supports Hyperhidrosis Awareness Month and educational initiatives. miraDry is recognized as a Proud Supporter of the organization.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Cynosure: Energy-based aesthetic device platform (lasers, RF, body contouring) sold to dermatologists, plastic surgeons, and med spas — directly overlapping miraDry's provider customer base and energy-based device category.
• Cutera: Aesthetic medical device company offering energy-based platforms (e.g., TruSculpt, excel V) to the same dermatologist and med-spa channel that miraDry serves, with comparable capital-equipment + consumable economics.
• InMode: Public medical aesthetics company selling minimally invasive and non-invasive energy-based platforms (BodyTite, Morpheus8, Evolve) into the same physician and med-spa channel as miraDry.
• BTL Industries: Privately held developer of non-invasive aesthetic devices (Emsculpt, Emface, Exilis) targeting body and face aesthetics through the same physician and med-spa channels as miraDry.
• Alma Lasers: Global energy-based aesthetic device manufacturer (laser, RF, ultrasound) selling into the same dermatology and aesthetic practice market; comparable go-to-market model and capital equipment + consumable economics.
• Solta Medical (Bausch Health): Aesthetic energy-device franchise (Thermage, Fraxel, Clear+Brilliant) sold into dermatology and plastic surgery practices — directly comparable business model and customer set to miraDry.
• Sciton: Private developer of laser and light-based aesthetic and medical platforms sold into dermatology, plastic surgery, and med-spa practices — comparable customer base and energy-device economics.
• Venus Concept: Aesthetic medical device company offering energy-based platforms for body contouring, skin tightening, and hair removal to the same physician and med-spa channel as miraDry.

Broad incumbents

• AbbVie (Botox / Allergan Aesthetics): Botox is the leading pharmaceutical alternative for axillary hyperhidrosis and the dominant non-surgical aesthetic injectable overall; competes for the same patient indication and the same provider relationships as miraDry.

Emerging players

• Dermadry: Direct-to-consumer iontophoresis device for hyperhidrosis of hands, feet, and underarms — competes for the same patient population as miraDry via a lower-cost, at-home alternative treatment modality.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/c/miraDryInc
• Facebookfacebook.com/miraDry
• LinkedInlinkedin.com/company/miradry
• Instagraminstagram.com/miradry
• Xx.com/miradry

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about miraDry